• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量 PCR 区分肺炎与定植的能力。

Ability of quantitative PCR to discriminate pneumonia from colonization.

机构信息

Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

出版信息

J Med Microbiol. 2020 May;69(5):705-711. doi: 10.1099/jmm.0.001190. Epub 2020 Apr 28.

DOI:10.1099/jmm.0.001190
PMID:32369002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7451042/
Abstract

pneumonia (PCP) is a severe disease affecting immunocompromised patients. Diagnosis is difficult due to the low sensitivity of direct examination and inability to grow the pathogen in culture. Quantitative PCR in bronchoalveolar lavage fluid (BAL) has high sensitivity, but limited specificity for distinguishing PCP from colonization. To assess the performance of an in-house quantitative PCR to discriminate between PCP and colonization. This was a single-centre retrospective study including all patients with a positive PCR result for in BAL between 2009 and 2017. Irrespective of PCR results, PCP was defined as the presence of host factors and clinical/radiological criteria consistent with PCP and (i) the presence of asci at direct examination of respiratory sample or (ii) anti-PCP treatment initiated with clinical response and absence of alternative diagnosis. Colonization was considered for cases who did not receive anti-PCP therapy with a favourable outcome or an alternative diagnosis. Cases who did not meet the above mentioned criteria were classified as 'undetermined'. Seventy-one patients with positive PCR were included (90 % non-HIV patients). Cases were classified as follows: 37 PCP, 22 colonization and 12 undetermined. Quantitative PCR values in BAL were significantly higher in patients with PCP versus colonization or undetermined (<0.0001). The cut-off of 5×10 copies/ml was able to discriminate PCP cases from colonization with 97 % sensitivity, 82 % specificity, 90 % positive predictive value and 95 % negative predictive value. Our quantitative PCR for in BAL was reliable to distinguish PCP cases from colonization in this predominantly non-HIV population.

摘要

卡氏肺孢子虫肺炎(PCP)是一种影响免疫功能低下患者的严重疾病。由于直接检查的敏感性低,且病原体无法在培养中生长,因此诊断较为困难。支气管肺泡灌洗液(BAL)中的定量 PCR 具有较高的敏感性,但对区分 PCP 与定植的特异性有限。评估一种内部定量 PCR 区分 PCP 和定植的性能。这是一项单中心回顾性研究,包括 2009 年至 2017 年间所有 BAL 中阳性 PCR 结果的患者。无论 PCR 结果如何,PCP 的定义为存在宿主因素和符合 PCP 的临床/放射学标准,并且 (i) 呼吸道样本的直接检查中存在有丝分裂或 (ii) 抗 PCP 治疗开始后具有临床反应且无其他诊断。对于未接受抗 PCP 治疗且预后良好或有其他诊断的患者,考虑为定植。未满足上述标准的病例被归类为“不确定”。共纳入 71 例阳性 PCR 的患者(90%为非 HIV 患者)。病例分为以下几类:37 例 PCP、22 例定植和 12 例不确定。与定植或不确定相比,PCP 患者的 BAL 定量 PCR 值显著更高(<0.0001)。5×10 拷贝/ml 的截止值能够以 97%的敏感性、82%的特异性、90%的阳性预测值和 95%的阴性预测值区分 PCP 病例与定植。我们在 BAL 中针对 的定量 PCR 能够可靠地区分非 HIV 人群中 PCP 病例与定植。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc15/7451042/5aa7762048d9/jmm-69-705-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc15/7451042/8c4ca8589107/jmm-69-705-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc15/7451042/5aa7762048d9/jmm-69-705-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc15/7451042/8c4ca8589107/jmm-69-705-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc15/7451042/5aa7762048d9/jmm-69-705-g002.jpg

相似文献

1
Ability of quantitative PCR to discriminate pneumonia from colonization.定量 PCR 区分肺炎与定植的能力。
J Med Microbiol. 2020 May;69(5):705-711. doi: 10.1099/jmm.0.001190. Epub 2020 Apr 28.
2
Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.联合检测肺部肺孢子菌 DNA 和血清(1->3)-β-D-葡聚糖对肺孢子菌肺炎和肺孢子菌定植的鉴别诊断。
J Clin Microbiol. 2013 Oct;51(10):3380-8. doi: 10.1128/JCM.01554-13. Epub 2013 Jul 31.
3
Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients.通过定量PCR检测耶氏肺孢子菌以鉴别免疫功能低下的HIV阳性和HIV阴性患者的定植与肺炎
J Clin Microbiol. 2016 Jun;54(6):1487-1495. doi: 10.1128/JCM.03174-15. Epub 2016 Mar 23.
4
Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients.两种实时荧光定量聚合酶链反应检测方法在诊断人类免疫缺陷病毒(HIV)感染及非HIV免疫功能低下患者耶氏肺孢子菌肺炎中的比较
Diagn Microbiol Infect Dis. 2015 Jun;82(2):143-7. doi: 10.1016/j.diagmicrobio.2015.03.006. Epub 2015 Mar 12.
5
Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.基于实时 PCR 检测的策略,用于区分免疫抑制患者中活跃的肺孢子菌肺炎和定植。
Clin Microbiol Infect. 2011 Oct;17(10):1531-7. doi: 10.1111/j.1469-0691.2010.03400.x. Epub 2011 Apr 12.
6
Semiquantitative Real-Time PCR to Distinguish Pneumocystis Pneumonia from Colonization in a Heterogeneous Population of HIV-Negative Immunocompromised Patients.半定量实时 PCR 区分 HIV 阴性免疫抑制患者异质人群中的肺孢子菌肺炎与定植。
Microbiol Spectr. 2021 Sep 3;9(1):e0002621. doi: 10.1128/Spectrum.00026-21. Epub 2021 Aug 4.
7
Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization.定量实时 PCR 和(1→3)-β-D-葡聚糖检测用于区分肺孢子菌肺炎和定植。
Clin Microbiol Infect. 2012 Jun;18(6):591-7. doi: 10.1111/j.1469-0691.2011.03605.x. Epub 2011 Oct 4.
8
Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients.定量 PCR 诊断免疫功能低下非 HIV 患者肺孢子菌肺炎。
Eur Respir J. 2012 Apr;39(4):971-8. doi: 10.1183/09031936.00095811. Epub 2011 Sep 15.
9
Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients.用耶氏肺孢子菌(Pj)定量聚合酶链反应区分免疫功能低下患者的耶氏肺孢子菌肺炎与耶氏肺孢子菌定植。
Eur J Clin Microbiol Infect Dis. 2014 Mar;33(3):331-6. doi: 10.1007/s10096-013-1960-3. Epub 2013 Aug 30.
10
High Diagnostic Value of a New Real-Time Pneumocystis PCR from Bronchoalveolar Lavage in a Real-Life Clinical Setting.在实际临床环境中,支气管肺泡灌洗新实时肺孢子菌PCR的高诊断价值
Respiration. 2016;92(3):144-9. doi: 10.1159/000448626. Epub 2016 Sep 6.

引用本文的文献

1
pneumonia in thoracic organ transplantation: Current perspectives and updates.胸器官移植中的肺炎:当前观点与进展
JHLT Open. 2025 Aug 7;10:100367. doi: 10.1016/j.jhlto.2025.100367. eCollection 2025 Nov.
2
Evaluation of the Loop-Mediated Isothermal Amplification Assay (LAMP) Eazyplex.环介导等温扩增检测法(LAMP)Eazyplex的评估
J Fungi (Basel). 2025 Apr 10;11(4):300. doi: 10.3390/jof11040300.
3
CRISPR-mediated detection of Pneumocystis transcripts in bronchoalveolar, oropharyngeal, and serum specimens for Pneumocystis pneumonia diagnosis.

本文引用的文献

1
The Fungal PCR Initiative's evaluation of in-house and commercial Pneumocystis jirovecii qPCR assays: Toward a standard for a diagnostics assay.真菌 PCR 倡议对内部和商业的肺孢子菌 jirovecii qPCR 检测方法的评估:朝着诊断检测方法的标准化迈进。
Med Mycol. 2020 Aug 1;58(6):779-788. doi: 10.1093/mmy/myz115.
2
Functional and Expression Analyses of the Genes Suggest Obligate Sexuality through Primary Homothallism within Host Lungs.基因的功能和表达分析表明,通过宿主肺部的初次同型交配,这些基因具有强制性的性别特征。
mBio. 2018 Feb 20;9(1):e02201-17. doi: 10.1128/mBio.02201-17.
3
Investigation of nosocomial pneumocystis infections: usefulness of longitudinal screening of epidemic and post-epidemic pneumocystis genotypes.
CRISPR介导的支气管肺泡、口咽和血清标本中肺孢子菌转录本检测用于肺孢子菌肺炎诊断
J Clin Invest. 2025 Mar 3;135(8). doi: 10.1172/JCI177241. eCollection 2025 Apr 15.
4
Diagnostic tests performance in detecting Pneumocystis jirovecii: A systematic review and meta-analysis.检测耶氏肺孢子菌的诊断试验性能:一项系统评价和荟萃分析。
Eur J Clin Microbiol Infect Dis. 2025 Apr;44(4):789-805. doi: 10.1007/s10096-025-05051-6. Epub 2025 Feb 3.
5
Quantitative real time PCR for distinction between infection/colonization in hospitalized patients.定量实时 PCR 用于区分住院患者的感染/定植。
Front Cell Infect Microbiol. 2024 Sep 24;14:1426200. doi: 10.3389/fcimb.2024.1426200. eCollection 2024.
6
Drug-induced pneumonitis risk in diffuse large B-cell/follicular lymphoma patients treated with R-CHOP-like regimen is associated with the use of granulocyte colony-stimulating growth factors.R-CHOP 样方案治疗弥漫性大 B 细胞/滤泡性淋巴瘤患者的药物性肺炎风险与粒细胞集落刺激因子的使用有关。
Cancer Med. 2024 Jan;13(1):e6898. doi: 10.1002/cam4.6898. Epub 2024 Jan 1.
7
The conventional diagnosis challenge: Real-time PCR and nested PCR correlation with the scoring system for individuals at high-risk of Pneumocystis jirovecii pneumonia.传统诊断挑战:实时 PCR 和巢式 PCR 与高危人群肺孢子菌肺炎评分系统的相关性。
Biomedica. 2023 Aug 31;43(Sp. 1):255-266. doi: 10.7705/biomedica.7020.
8
Quick versus Quantitative: Evaluation of Two Commercial Real-Time PCR Assays for the Detection of Pneumocystis jirovecii from Bronchoalveolar Lavage Fluids.快速与定量:两种商业实时 PCR 检测试剂盒用于检测支气管肺泡灌洗液中肺孢子菌的比较。
Microbiol Spectr. 2023 Aug 17;11(4):e0102123. doi: 10.1128/spectrum.01021-23. Epub 2023 Jun 1.
9
Performance of microbiological tests for tuberculosis diagnostic according to the type of respiratory specimen: A 10-year retrospective study.根据呼吸道标本类型评估结核分枝杆菌诊断微生物学检测的性能:一项 10 年回顾性研究。
Front Cell Infect Microbiol. 2023 Mar 2;13:1131241. doi: 10.3389/fcimb.2023.1131241. eCollection 2023.
10
Development and validation of tools for predicting the risk of death and ICU admission of non-HIV-infected patients with pneumonia.开发和验证工具,用于预测非 HIV 感染肺炎患者的死亡和 ICU 入院风险。
Front Public Health. 2022 Nov 8;10:972311. doi: 10.3389/fpubh.2022.972311. eCollection 2022.
医院获得性肺孢子菌感染的调查:纵向筛查流行和流行后肺孢子菌基因型的有用性。
J Hosp Infect. 2018 Jul;99(3):332-345. doi: 10.1016/j.jhin.2017.09.015. Epub 2017 Sep 21.
4
detection in asymptomatic patients: what does its natural history tell us?无症状患者中的检测:其自然史能告诉我们什么?
F1000Res. 2017 May 23;6:739. doi: 10.12688/f1000research.10619.1. eCollection 2017.
5
Molecular Demonstration of a Pneumocystis Outbreak in Stem Cell Transplant Patients: Evidence for Transmission in the Daycare Center.干细胞移植患者中肺孢子菌暴发的分子学证明:日托中心存在传播的证据
Front Microbiol. 2017 Apr 24;8:700. doi: 10.3389/fmicb.2017.00700. eCollection 2017.
6
Diagnosis and management of Pneumocystis jirovecii infection.耶氏肺孢子菌感染的诊断与管理
Expert Rev Anti Infect Ther. 2017 May;15(5):435-447. doi: 10.1080/14787210.2017.1305887. Epub 2017 Mar 20.
7
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients.ECIL 指南:非 HIV 感染血液病患者肺孢子菌肺炎的治疗。
J Antimicrob Chemother. 2016 Sep;71(9):2405-13. doi: 10.1093/jac/dkw158. Epub 2016 May 12.
8
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.ECIL 指南:血液恶性肿瘤和造血干细胞移植受者中肺孢子菌肺炎的诊断。
J Antimicrob Chemother. 2016 Sep;71(9):2386-96. doi: 10.1093/jac/dkw156. Epub 2016 May 12.
9
Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.卡氏肺孢子虫肺炎:血液系统恶性肿瘤和造血干细胞移植受者仍需关注。
J Antimicrob Chemother. 2016 Sep;71(9):2379-85. doi: 10.1093/jac/dkw155. Epub 2016 May 12.
10
Ten years of R&D and full automation in molecular diagnosis.十年分子诊断研发与全自动化历程。
Future Microbiol. 2016;11(3):403-25. doi: 10.2217/fmb.15.152.